MIRM
Mirum Pharmaceuticals, Inc.
32.34
USD
This page is just a preview of the data found in TrendSpider’s full version
Mirum Pharmaceuticals, Inc. stock is up 13.04% since 30 days ago. The next earnings date is Mar 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 4 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 CALLs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 24 Nov 16:03 | 19 Jan, 2024 | 30.00 | 298 | ||
| 24 Nov 16:03 | 19 Jan, 2024 | 30.00 | 298 |
Mirum Pharmaceuticals, Inc. focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease.
